Company Filing History:
Years Active: 2012-2022
Title: Jens Fomsgaard: A Visionary Inventor in Pharmaceutical Innovation
Introduction
Jens Fomsgaard, a prominent inventor based in Farum, Denmark, is recognized for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of 8 patents, Fomsgaard has made strides in the development of essential medical products, particularly in the area of peptide-based therapies.
Latest Patents
Fomsgaard's latest patents focus on the manufacture of degarelix, a drug used for treating prostate cancer. He has developed innovative methods for producing a lyophilized degarelix product that, when reconstituted with water for injection at an amount of 20 mg/ml, demonstrates a viscosity of up to 15 mPas. Additionally, his invention encompasses a lyophilized degarelix drug substance that upon dissolution in water at the same concentration shows a viscosity of up to 3.2 mPas. These advancements underscore the importance of optimizing drug formulations for improved patient outcomes.
Career Highlights
Throughout his career, Jens Fomsgaard has had the privilege of working with renowned companies in the biotechnology field. Notably, he has contributed his expertise at Ferring B.V. and Polypeptide Laboratories A/S. His work has been instrumental in advancing therapeutic solutions that address critical health issues.
Collaborations
Fomsgaard has collaborated with several prominent professionals in the industry, including Jon Holbech Rasmussen and Grégoire Schwach. Together, they have fostered a creative environment that drives innovation and enhances pharmaceutical development.
Conclusion
Jens Fomsgaard exemplifies the spirit of innovation within the pharmaceutical industry. With a strong commitment to improving therapeutic options, his patents and collaborative efforts continue to have a lasting impact on healthcare. As he progresses in his career, Fomsgaard remains a key figure to watch in the realm of medical inventions and innovations.